What are the long term effects of daily vascepa use?

What risks do patients report after years of daily Vascepa?

Patients taking Vascepa (icosapent ethyl) long-term have reported muscle pain, joint stiffness, and occasional gout flares. These complaints appear in voluntary adverse event reports and appear more frequently after 12–24 months of continuous use. Some patients describe persistent fatigue and mild bleeding tendencies, such as increased bruising.

How does Vascepa affect bleeding risk over time?

Vascepa prolongs bleeding time because it interferes with platelet function. Clinical studies lasting up to five years show a modest increase in serious bleeding events compared with placebo. Patients on blood thinners or with upcoming surgeries should inform their doctors, since the risk grows with age and concurrent medications.

What happens to liver enzymes and heart rhythm during long-term use?

Liver enzymes may rise modestly in a small percentage of users. Periodic blood tests are recommended. A separate clinical signal for atrial fibrillation or flutter emerged in the REDUCE-IT trial, where more patients on Vascepa than on placebo developed these rhythm disturbances. Heart rhythm monitoring is suggested for people with prior history.

Can Vascepa be taken safely indefinitely?

Most patients tolerate Vascepa for years without major issues. The REDUCE-IT trial followed participants for a median of 4.9 years and found cardiovascular benefits that outweigh the genotyped risk profile. Regular lab checks and symptom tracking are recommended.